They have to partner the program at some point the question is just a matter of when and if they retain rights in any regions. The company has said as much. But they also point out the cash runway through late 2027 includes a phase 3 for RSV so going it alone is on the table for sure, although I think it is more likely they partner prior to phase 3 which is my preference as well
Market Data 
Markets 
AI
